Publication: Therapeutic potential of CD73+ mesenchymal stem cells for myocardial infarction and beyond
| dc.contributor.author | Hou, Huifang | |
| dc.contributor.author | Zheng, Miaoyun | |
| dc.contributor.author | Pan, Kai | |
| dc.contributor.author | Wang, Guodong | |
| dc.contributor.author | Li, Zongjin | |
| dc.contributor.author | Li, Qiong | |
| dc.contributor.department | BiologÃa Celular e HistologÃa | es |
| dc.date.accessioned | 2025-07-07T10:35:42Z | |
| dc.date.available | 2025-07-07T10:35:42Z | |
| dc.date.issued | 2025 | |
| dc.description.abstract | Extracellular adenine nucleotides serve as crucial signaling molecules and influence a broad spectrum of physiological and pathological processes. CD73, the rate-limiting enzyme in the metabolism of extracellular adenine nucleotides, is ubiquitously expressed on various cell types, particularly stem cells. CD73+ mesenchymal stem cells (MSCs) have emerged as promising candidates for therapeutic applications due to their immunomodulatory and pro-regenerative properties. Numerous studies have highlighted the crucial role of CD73 in mediating tissue protection in myocardial infarction (MI). In this review, a brief overview of the cell type-specific expression, regulatory effects of CD73 on MSCs, and proangiogenic and immunomodulatory mechanisms is provided, with a focus on current findings concerning the protective functions of CD73 in the context of MI within the framework of stem cell therapy | es |
| dc.format | application/pdf | es |
| dc.format.extent | 11 | es |
| dc.identifier.citation | Histology and Histopathology Vol. 40, nº07 (2025) | |
| dc.identifier.doi | https://doi.org/10.14670/HH-18-859 | |
| dc.identifier.issn | 0213-3911 | |
| dc.identifier.issn | 1699-5848 | |
| dc.identifier.uri | http://hdl.handle.net/10201/157042 | |
| dc.language | eng | es |
| dc.publisher | Universidad de Murcia, Departamento de Biologia Celular e Histiologia | es |
| dc.relation | Sin financiación externa a la Universidad | es |
| dc.rights | info:eu-repo/semantics/openAccess | es |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.subject | Mesenchymal stem cells (MSCs) | es |
| dc.subject | Myocardial infarction (MI) | es |
| dc.subject | Angiogenesis | es |
| dc.subject | Immune regulation | es |
| dc.subject.other | CDU::6 - Ciencias aplicadas::61 - Medicina::616 - PatologÃa. Medicina clÃnica. OncologÃa | es |
| dc.title | Therapeutic potential of CD73+ mesenchymal stem cells for myocardial infarction and beyond | es |
| dc.type | info:eu-repo/semantics/article | es |
| dspace.entity.type | Publication | es |
Este Ãtem está sujeto a una licencia Creative Commons. http://creativecommons.org/licenses/by-nc-nd/4.0/